Hanne Damgaard Jensen

Directeur des opérations chez CURASIGHT A/S

Fortune : 5 605 $ au 31/05/2024

Health Technology

Consumer Services

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Jan van de Winkel	M	63	GENMAB A/S	25 ans
Andreas Kjaer	M	61	CURASIGHT A/S	11 ans
Ulrich Krasilnikoff	M	57	CURASIGHT A/S	8 ans
Carsten Nielsen	M	41	CURASIGHT A/S	11 ans
Per Falholt	M	65	CURASIGHT A/S	4 ans
Jacob Madsen	M	52	CURASIGHT A/S	11 ans
Henrik Ehlers Wulff	M	54	NOVO NORDISK A/S	25 ans
Karsten Munk Knudsen	M	53	NOVO NORDISK A/S	25 ans
Charlotte Vedel	M	56	CURASIGHT A/S	4 ans
Anthony Pagano	M	46	GENMAB A/S	17 ans
Lars Trolle	M	57	CURASIGHT A/S	10 ans
Martine van Vugt	M	71	GENMAB A/S	23 ans
Camilla Sylvest	F	52	NOVO NORDISK A/S	28 ans
Anders Gersel Pedersen	M	73	GENMAB A/S	21 ans
Birgitte Stephensen	F	63	GENMAB A/S	22 ans
Kirsten Drejer	M	68	CURASIGHT A/S	3 ans
Nic Gillings	M	56	CURASIGHT A/S	-

Graphique Relationnel

Relation dans plusieurs entreprises

Anciennes relations

Nom	Sexe	Age	Sociétés liées	Collaboration
Michael Blair Widmer	M	76	GENMAB A/S	11 ans
Bo Kruse	M	52	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. GENMAB A/S	15 ans
Jakob Riis	M	58	NOVO NORDISK A/S	21 ans
Claus Juan Møller-San Pedro	M	62	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. GENMAB A/S	21 ans
Ole Baadsgaard	M	72	GENMAB A/S	-
Christina Hahner	F	-	GENMAB A/S	-
Jesper Brandgaard	M	60	NOVO NORDISK A/S	20 ans
Karsten Havkrog Pedersen	M	74	GENMAB A/S	11 ans
David Kauffmann	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	5 ans
Burt Malkiel	M	90	GENMAB A/S	11 ans
Tom Vink	M	61	GENMAB A/S	-
Nedjad Losic	M	55	GENMAB A/S	-
Lisa N. Drakeman	M	70	GENMAB A/S	11 ans
Michael K. Bauer	M	60	GENMAB A/S	14 ans
Hans Henrik Munch-Jensen	M	64	GENMAB A/S	8 ans
Patrick Loustau	M	61	NOVO NORDISK A/S	14 ans
Christopher Yallop	M	-	NOVO NORDISK A/S	6 ans
Henrik Poulsen	M	57	NOVO NORDISK A/S	1 ans
Martin Olin	M	55	NOVO NORDISK A/S	4 ans
Per Gullestrup	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 ans
Jan Mikkelsen	M	65	NOVO NORDISK A/S	11 ans
Jens Munch-Hansen	M	69	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 ans
Annette Stube	F	57	NOVO NORDISK A/S	11 ans
René Djurup	M	-	NOVO NORDISK A/S	4 ans
Rikke Glahn Ren	F	-	GENMAB A/S	-
Jorgen Petersen	M	-	GENMAB A/S	-
Patrick van Berkel	M	55	GENMAB A/S	9 ans
Anna Héléne Barnekow	F	60	NOVO NORDISK A/S	2 ans
Gitte L. Pedersen	F	61	NOVO NORDISK A/S	10 ans
Zaiton binti Jamaluddin	F	65	NOVO NORDISK A/S	8 ans
Wolfgang Amann	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	-
Peter Nordkild	M	69	NOVO NORDISK A/S	2 ans
Joseph Fred Yospe	M	66	GENMAB A/S	2 ans
Paul W. H. I. Parren	M	60	GENMAB A/S	16 ans
Christian Hansen	M	58	NOVO NORDISK A/S	7 ans
Anker Gunvald Lundemose	M	63	NOVO NORDISK A/S	4 ans
Peter David Suzdak	M	65	NOVO NORDISK A/S	7 ans
Donald Lee Drakeman	M	70	GENMAB A/S	-
Jan Ulf Sigvar J. Johansson	M	79	NOVO NORDISK A/S	7 ans
Bruce Carter	M	80	NOVO NORDISK A/S	4 ans
Jan Öhrström	M	67	NOVO NORDISK A/S	9 ans
Peter James Arthur Benson	M	69	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	2 ans
Bo Jesper Hansen	M	66	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	5 ans
Christian Gröndahl	M	60	NOVO NORDISK A/S	14 ans
Annarie Lyles	M	63	GENMAB A/S	-
Florian Schönharting	M	55	GENMAB A/S	-
Jens Jesper Ovesen	M	67	NOVO NORDISK A/S	4 ans
Finn M. Ulrich	M	-	NOVO NORDISK A/S	8 ans
Per Toft Valstorp	M	75	NOVO NORDISK A/S	14 ans
Michael Wolff Jensen	M	53	GENMAB A/S	3 ans
Thomas Feldthus	M	64	NOVO NORDISK A/S	3 ans
Valeta A. Gregg	M	72	NOVO NORDISK A/S	5 ans
Peder Holk Nielsen	M	67	NOVO NORDISK A/S	5 ans
Jette Traulsen	M	-	NOVO NORDISK A/S	5 ans
Joan Schmidt	F	60	NOVO NORDISK A/S	20 ans

Statistiques

Pays	Relations	% du total
Danemark	72	100,00%

Age des relations

Actives

Passées

Homme

Femme

Administrateurs

Exécutifs

Provenance des relations